Ebit Cambiamento Data
AbbVie USD 4.52B 378M 2023-09
Acadia Pharmaceuticals USD 34.94M 92.72M 2023-12
Agios Pharmaceuticals USD -106277000 5.38M 2023-12
ALKERMES USD 49.85M 189.34M 2023-09
Alnylam Pharmaceuticals USD -116404000 330.27M 2023-12
Amgen USD 1.8B 254M 2023-12
Biogen USD 512M 226.7M 2023-12
BioMarin Pharmaceutical USD 28.22M 2.56M 2023-12
Cytokinetics USD -127418000 5.15M 2023-12
Dynavax Technologies USD -7005000 12.01M 2023-12
Enanta Pharmaceuticals USD -31030000 5.68M 2023-09
Exelixis USD -17583000 95.43M 2023-09
Gilead Sciences USD 2.15B 475M 2023-12
Halozyme Therapeutics USD 101.04M 10.26M 2023-12
Incyte USD 205.23M 10.1M 2023-12
Intra Cellular Therapies USD -34097000 4.38M 2023-12
Ionis Pharmaceuticals USD -6123000 137.14M 2023-12
Nektar Therapeutics USD -33504000 541K 2023-09
Neurocrine Biosciences USD 141.2M 67.6M 2023-09
Pfizer USD -125000000 2.34B 2023-12
Regeneron Pharmaceuticals USD 1B 208.1M 2023-12
Repligen USD 9.47M 22.49M 2023-12
Rigel Pharmaceuticals USD -4465000 802K 2023-09
Sarepta Therapeutics USD -20842000 112.68M 2023-09
Teva Pharmaceutical Industries USD 855M 29M 2023-09
Ultragenyx Pharmaceutical USD -122049000 23.05M 2023-12
Vertex Pharmaceuticals USD 1.04B 11.7M 2023-09
Xoma USD -5787000 1.4M 2023-09



Neurocrine Biosciences - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.